Amanote Research
Register
Sign In
P33: Antenatal Administration of a Potential Interleukin‐6 Receptor Antagonist Prevents Inflammation‐induced Preterm Birth and Fetal Tissue Injury
American Journal of Reproductive Immunology
- United Kingdom
doi 10.1111/aji.32_13120
Full Text
Open PDF
Abstract
Available in
full text
Categories
Gynecology
Reproductive Medicine
Immunology
Obstetrics
Allergy
Date
May 1, 2019
Authors
Unknown
Publisher
Wiley
Related search
P02: Optimal Dose and Time of Administration of Rytvela for Prevention of Inflammation‐induced Preterm Birth and Fetal Tissue Injury
American Journal of Reproductive Immunology
Gynecology
Reproductive Medicine
Immunology
Obstetrics
Allergy
Novel Toll-Like Receptor-4 Antagonist (+)-Naloxone Protects Mice From Inflammation-Induced Preterm Birth
Scientific Reports
Multidisciplinary
Targeting Toll-Like Receptor-4 to Tackle Preterm Birth and Fetal Inflammatory Injury
Clinical and Translational Immunology
Allergy
Immunology
Nursing
Inflammation and Cardiovascular Disease: Role of the Interleukin-1 Receptor Antagonist
Circulation
Cardiovascular Medicine
Physiology
Cardiology
Antenatal Glucocorticoids, Magnesium Sulfate, and Mode of Birth in Preterm Fetal Small for Gestational Age
American Journal of Obstetrics and Gynecology
Gynecology
Obstetrics
Interleukin-1, Interleukin-1 Receptor, and Interleukin-1 Receptor Antagonist
Proceedings of the Nutrition Society
Medicine
Nutrition
Dietetics
Expression of Interleukin-1 and Interleukin-1 Receptor Antagonist by Human Rheumatoid Synovial Tissue Macrophages
Clinical Immunology and Immunopathology
Interleukin 6 Inhibition by Triptolide Prevents Inflammation in a Mouse Model of Ulcerative Colitis
Experimental and Therapeutic Medicine
Medicine
Cancer Research
Immunology
Microbiology
Disruption of Interleukin-18, but Not Interleukin-1, Increases Vulnerability to Preterm Delivery and Fetal Mortality After Intrauterine Inflammation
American Journal of Pathology
Forensic Medicine
Pathology
